LRMR · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2025-04-30 compared with 2024-10-30 · 4 added, 2 removed, 23 unchanged (21% of the section changed)
Other Information
+Added: Rule 10b5-1 Trading Arrangements
+Added: During the quarter ended March 31, 2025 , none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408(a) of Regulation S-K).
The exhibits filed as part of this Quarterly Report are set forth on the Exhibit Index, which is incorporated herein by reference.
11 unchanged sentences
LARIMAR THERAPEUTICS, INC.
−Removed: October 30, 2024
+Added: April 30, 2025
/s/ Carole S.
3 unchanged sentences
(Principal Executive Officer)
−Removed: October 30, 2024
+Added: April 30, 2025
/s/ Michael Celano
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.